1-3 of 3
Philip R. Hamann
Close
Sort by
Journal Articles

B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model

Kyri Dunussi-Joannopoulos, Gerald E. Hancock, Arthur Kunz, Martin Hegen, Xiaochuan X. Zhou, Barbara J. Sheppard, Jennifer Lamothe, Evelyn Li, Hak-Ling Ma, Philip R. Hamann, Nitin K. Damle, Mary Collins
Journal: Blood
Blood (2005) 106 (7): 2235–2243.
https://doi.org/10.1182/blood-2004-11-4547
Published: 2005
Journal Articles

Antibody-Targeted Chemotherapy with Immunoconjugates of Calicheamicin: Differential Anti-Tumor Activity of Conjugated Calicheamicin Targeted to B-Cell Lymphoma Via B-Cell Lineage Specific Molecules CD19, CD20 and CD22.

John F. DiJoseph, Douglas C. Armellino, Maureen M. Dougher, Arthur Kunz, Erwin R. Boghaert, Philip R. Hamann, Karen Zinkewich-Peotti, Nitin K. Damle
Journal: Blood
Blood (2004) 104 (11): 2490.
https://doi.org/10.1182/blood.V104.11.2490.2490
Published: 2004
Journal Articles

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

John F. DiJoseph, Douglas C. Armellino, Erwin R. Boghaert, Kiran Khandke, Maureen M. Dougher, Latha Sridharan, Arthur Kunz, Philip R. Hamann, Boris Gorovits, Chandrasekhar Udata, Justin K. Moran, Andrew G. Popplewell, Sue Stephens, Philip Frost, Nitin K. Damle
Journal: Blood
Blood (2004) 103 (5): 1807–1814.
https://doi.org/10.1182/blood-2003-07-2466
Published: 2004